Literature DB >> 9647592

Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up.

P Thorson1, R T Vollmer, C Arcangeli, D W Keetch, P A Humphrey.   

Abstract

Prostate cancer screening and early detection efforts have resulted in the identification of smaller volume carcinomas of the prostate. We evaluated the diagnostic features of minimal (< 1 mm) carcinoma in sextant needle biopsy specimens of the prostate and in follow-up analyzed the features of the corresponding carcinomas in the whole gland. We reviewed specimens from 50 consecutive patients who had minimal carcinoma in needle biopsy tissue and who had undergone radical prostatectomy. Histologic grade, tumor size, pathologic stage, and margin status of the 50 carcinomas in the whole gland in which the carcinoma size was minimal in the sextant needle biopsy specimen were compared with those of 50 carcinomas in the whole gland in which carcinoma size was greater than 1 mm in the needle biopsy specimen. The most common morphologic features of these minimal carcinomas were nucleomegaly (96%), infiltrative growth pattern (88%), intraluminal secretions (78%), prominent nucleoli (64%), associated high-grade prostatic intraepithelial neoplasia (40%), amphophilic cytoplasm (36%), hyperchromatic nuclei (30%), and intraluminal crystalloids (22%). Perineural invasion (2%), collagenous micronodules (2%) and mitotic figures (2%) were uncommon. The mean tumor volume in the whole gland of carcinomas corresponding to minimal carcinoma in a needle biopsy specimen was significantly smaller (P=.029) at 1.1 mL than it was in carcinomas with tumor greater than 1 mm in the needle biopsy specimen at 1.6 mL, but other pathologic features of carcinoma in the whole gland were not significantly different. In conclusion, a constellation of morphologic attributes is important for establishment of a diagnosis of minimal carcinoma of the prostate in needle biopsy specimen. Most (82%) of the corresponding prostate cancers in the whole gland were pathologically significant.

Entities:  

Mesh:

Year:  1998        PMID: 9647592

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

1.  Variations in the processing of prostatic needle cores in the UK; what is safe?

Authors:  O Biedrzycki; M Varma; D M Berney
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

Review 2.  Histopathology reporting of prostate needle biopsies. 2005 update.

Authors:  Rodolfo Montironi; Remigio Vela Navarrete; Antonio Lopez-Beltran; Roberta Mazzucchelli; Gregor Mikuz; Aldo V Bono
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

Review 3.  Diagnosis of adenocarcinoma in prostate needle biopsy tissue.

Authors:  P A Humphrey
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

Review 4.  Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.

Authors:  Vineet K Dhiman; Michael J Bolt; Kevin P White
Journal:  Nat Rev Genet       Date:  2017-12-27       Impact factor: 53.242

Review 5.  Histopathology of Prostate Cancer.

Authors:  Peter A Humphrey
Journal:  Cold Spring Harb Perspect Med       Date:  2017-10-03       Impact factor: 6.915

6.  Minimal focus of adenocarcinoma on prostate biopsy: clinicopathological correlations.

Authors:  X Leroy; S Aubert; A Villers; C Ballereau; D Augusto; B Gosselin
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

7.  Periacinar retraction clefting in the prostatic needle core biopsies: an important diagnostic criterion or a simple artifact?

Authors:  Bozo Kruslin; Davor Tomas; Hermann Rogatsch; Irena Novosel; Hrvoje Cupić; Mladen Belicza; Ognjen Kraus; Gregor Mikuz
Journal:  Virchows Arch       Date:  2003-07-24       Impact factor: 4.064

8.  Gleason grading of prostatic adenocarcinoma with glomeruloid features on needle biopsy.

Authors:  Tamara L Lotan; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2009-01-06       Impact factor: 3.466

Review 9.  Single foci prostate cancer: current diagnosis and management.

Authors:  Ioannis Efthimiou; Konstadinos Skrepetis; Elefteria Bournia
Journal:  Curr Urol       Date:  2013-07-28

10.  p40 as a Basal Cell Marker in the Diagnosis of Prostate Glandular Proliferations: A Comparative Immunohistochemical Study with 34betaE12.

Authors:  Hermann Brustmann
Journal:  Patholog Res Int       Date:  2015-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.